Man Group
BVS icon

Man Group’s Bioventus BVS Stock Holding History

Man Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$610K Buy
+64,589
New +$617K ﹤0.01% 2004
2024
Q3 		– Sell
-24,998
Closed -$144K – 1981
2024
Q2 		$144K Sell
24,998
-87,908
-78% -$482K ﹤0.01% 1927
2024
Q1 		$587K Buy
112,906
+43,232
+62% +$211K ﹤0.01% 1732
2023
Q4 		$367K Buy
+69,674
New +$276K ﹤0.01% 1767

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group's BVS Position: Q2 2026 in Review

Man Group opened a new position in Bioventus (BVS) in Q2 2026: 64,589 shares worth $610K. The stake represents ﹤0.01% of the portfolio and ranks #2004 among its holdings. This is a return to the name: Man Group previously reported a position in BVS as recently as Q2 2024.

Man Group first reported a position in BVS in Q4 2023 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Man Group held 64,589 shares of Bioventus worth $610K as of Q2 2026.
  • Bioventus was a new Man Group position in Q2 2026.
  • Bioventus made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2004 holding.
  • Man Group first reported a position in Bioventus in Q4 2023 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.